Press release
Rising Prevalence Of ADHD Spurs Growth In The Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutic Market: An Emerging Driver Transforming The Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Landscape
Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics
What Is the Projected Growth of the Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market?
The market size for therapeutics related to attention deficit hyperactivity disorder (ADHD) has seen significant growth in recent times. There is an anticipated increase from $13.21 billion in 2024 to $14.1 billion in 2025, with a compound annual growth rate (CAGR) of 6.7%. Factors such as increased awareness and diagnostic screenings, a rise in ADHD cases, progression in treatment options, enhancements in healthcare infrastructure, and the broadening of health insurance coverage can be cited as the key drivers of growth during the historical period.
There is an anticipated surge in the ADHD (attention deficit hyperactivity disorder) treatment market in the upcoming years. The market is predicted to swell to a substantial $17.25 billion by 2029, progressing at a compound annual growth rate of 5.2%. This upwards trend in the future can be credited to advancements in genetic studies and personalized medicine, enhanced public consciousness about mental health, worldwide and domestic mental health campaigns, the development of telehealth, and the incorporation of behavioral therapies. The forecast period will also see predominant trends like technological breakthroughs in treatment methodologies, research and development endeavors, the incorporation of digital therapeutics, precision medicine strategies, and innovative drug delivery systems.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=14042
What Are the Different Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Segments?
The attention deficit hyperactivity disorder (ADHD) therapeutics market covered in this report is segmented -
1) By Drug Type: Stimulants, Non-Stimulants
2) By Psychotherapy: Behavior Therapy, Cognitive Behavioral Therapy, Interpersonal Psychotherapy, Family Therapy
3) By Age Group: Pediatric And Adolescent, Adult
4) By Distribution Channel: Hospital Pharmacies, Specialty Clinics, Retail Pharmacies, E-Commerce
Subsegments:
1) By Stimulants: Amphetamine-Based Stimulants, Methylphenidate-Based Stimulants
2) By Non-Stimulants: Atomoxetine, Guanfacine, Clonidine
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=14042&type=smp
What Are the Primary Drivers Shaping the Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market?
The growth of the attention-deficit hyperactivity disorder (ADHD) therapeutics market is projected to be spurred by the escalating prevalence of the disorder. This refers to the increased number of people being diagnosed with this neurodevelopmental disorder over a period of time. The goal of ADHD therapeutics is to address the complex nature of the disorder, enhancing symptom management, reducing functional impairment, improving life quality, and the overall well-being of those impacted by ADHD. As an example, in January 2023, Guardian reports revealed that approximately 170,000 diagnosed patients were on ADHD medication in 2022, marking a 20.4% rise from the 141,000 diagnosed patients in the corresponding period in 2021. Consequently, the rising prevalence of ADHD is fueling the expansion of the attention-deficit hyperactivity disorder (ADHD) therapeutic market.
Which Companies Are Leading in the Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market?
Major companies operating in the attention deficit hyperactivity disorder (ADHD) therapeutics market are Pfizer Inc., Johnson And Johnson Services Inc., Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical's, Eli Lilly and Company, Otsuka Pharmaceutical Co. Ltd., UCB S.A., Amneal Pharmaceuticals LLC, Lupin Ltd., Mallinckrodt Pharmaceuticals Inc., Hisamitsu Pharmaceutical Co. Inc., Purdue Pharma L.P., Arbor Pharmaceuticals LLC, Tris Pharma Inc., NEOS Therapeutic Inc., Concert Pharmaceuticals Inc., Vayarin AG, Rhodes Pharmaceuticals L.P., KemPharm Inc., Impax Laboratories Inc., Aevi Genomic Medicine, Adlon Therapeutics L.P., Ironshore Pharmaceuticals Inc., Highland Therapeutics Inc.
What Are the Major Trends Shaping the Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market?
Leading businesses in the ADHD therapeutics market are concentrating on incorporating digital innovations such as Endeavor OTC digital therapeutics versions for ADHD in response to the escalating demand for digital solutions and the growing necessity for remote healthcare. Digital therapeutics, backed by evidence-based therapeutic interventions and propelled by advanced software applications, aim to prevent, manage or cure medical ailments or diseases. These therapies are designed to function independently or in conjunction with traditional medical treatments. For example, in June 2023, Akili, a digital healthcare company based in the US, rolled out an OTC form of its video game-based digital therapeutic specifically for adults with ADHD. This OTC model, named EndeavorOTC, aims to enhance attention, time management, and organization skills. This action is in line with the success of Akili's FDA-approved prescription video game therapy, EndeavorRx, created for children with ADHD. The OTC variant offers a non-pharmaceutical treatment alternative to adults for the management of ADHD symptoms.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/attention-deficit-hyperactivity-disorder-adhd-therapeutics-global-market-report
What Are the Top Revenue-Generating Geographies in the Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market?
North America was the largest region in the attention deficit hyperactivity disorder (ADHD) therapeutic market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the attention deficit hyperactivity disorder (ADHD) therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market?
2. What is the CAGR expected in the Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market?
3. What Are the Key Innovations Transforming the Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Industry?
4. Which Region Is Leading the Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rising Prevalence Of ADHD Spurs Growth In The Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutic Market: An Emerging Driver Transforming The Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Landscape here
News-ID: 4020106 • Views: …
More Releases from The Business Research Company
Seed Treatment Fungicides Market to Grow at 9.3% CAGR, Reaching $3.15 Billion by …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Seed Treatment Fungicides Market Outlook: How is the Market Expected to Grow by 2025?
Over the past few years, the market for seed treatment fungicides has seen robust growth. Its market value is projected to rise from $2.07 billion in 2024 to $2.21 billion in 2025, signifying a compound annual…
Rheology Modifiers Market Growth to be Driven by Emerging Trends | $10.92 Billio …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Rheology Modifiers Industry?
There has been a consistent expansion in the size of the rheology modifiers market in the past few years. The market, which was worth $8.59 billion in 2024, is projected to increase to $8.89 billion in 2025, demonstrating a compound…
Polyurethane Foam Market to Record 8.4% CAGR Growth Through 2029 | Global Analys …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Polyurethane Foam Market Outlook: How is the Market Expected to Grow by 2025?
In recent years, the size of the polyurethane foam market has experienced substantial growth. It is projected to increase from a value of $54.27 billion in 2024 to $57.26 billion in 2025, indicating a compound annual growth…
Pharmaceutical Intermediates Market Size to Reach $46.04 Billion by 2029 | Growt …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Pharmaceutical Intermediates Industry?
There has been consistent growth in the market size of pharmaceutical intermediates over the past few years. The market is predicted to increase from a value of $33.37 billion in 2024, up to $34.95 billion in 2025, with a compound…
More Releases for ADHD
My ADHD Life Journal by Meryl Bengtsson Offers a Fresh, Reflective Tool for ADHD …
Image: https://www.globalnewslines.com/uploads/2025/05/1748624322.jpg
In a world that often pushes individuals with ADHD to "try harder" or "focus more," author and ADHD life coach Meryl Bengtsson invites you to try something radically different. With her book and courses, she encourages you to listen to yourself. Her new book, My ADHD Life Journal: Building Self-Awareness [https://www.amazon.co.uk/My-ADHD-Life-Journal-Self-Awareness/dp/1967679673/], is a deeply personal and practical resource designed to guide individuals on a journey of gentle reflection and…
ADHD Awareness Month: Dance Academy Founder Shares How Dance Helps Manage ADHD
This ADHD Awareness Month, Nix Academy - an up and coming dance and performing arts school - is highlighting the powerful impact of dance on managing ADHD symptoms. Founded by Nicky Rowe, who herself has ADHD, the academy has become a beacon of inclusivity, with around 40% of its students identifying as neurodiverse.
"Dance has been my lifeline in managing ADHD," says Nicky Rowe, Founder and Principal Teacher at Nix Academy.…
Global ADHD Drugs Market Research Report 2017
Qyresearchreports include new market research report "Global ADHD Drugs Market Research Report 2017" to its huge collection of research reports.
The research report offers a comprehensive analysis of the global ADHD Drugs market, emphasizing on the key factors impacting the growth of the market. The factors affecting the growth of the market have been studied thoroughly and valuation of the market has been provided in the report. This report provides accurate…
ADHD Answers from an ADHD Teen Brings Help to Parents, ADHD Boys
Sept. 4, 2006--Parents of boys with Attention Deficit Disorder (ADHD) have a new place to find answers to questions, problem-solving suggestions, and general help and support, both for their sons and for themselves. But the help comes from a source some will find surprising. \"Talk Back with Jack\" offers a forum for 11-year-old Jack Dixon to offer help and advice to ADHD boys and their parents as part of That\'s…
ADHD Myths — What If There Really Isn’t Anything Wrong with ADHD Children?
February 6, 2006 (Washington, D.C.) - An ADHD diagnosis can often signal a lifetime of struggles for children. But consider the case of Robbie Raffino.
Robbie used to rise every day like most eight-year-olds. He'd wipe the sleepiness from his eyes, throw on shorts and shirt that don't match and eat cereal while watching cartoons.
But the innocence ended there. He'd swallow his Ritalin, hop on the school bus and enter…
Making ADHD Kids Winners
(Washington, D.C.) January 31, 2006 - Parents of children with ADHD, or Attention Deficit Disorder, are no different than other parents-they want their kids to be winners in life. Like all children, kids with ADHD face many unique challenges in life.
So what lessons can ADHD families learn from elite athletes preparing to battle for the Super Bowl Championship?
According to Kirk Martin, Founder of educational organization Celebrate! ADHD, “Children with…
